Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/ cell-binding peptide (P-15) in the treatment of human infrabony defects

Clinical Oral Investigations

Volumn 12, Issue 3, 2008, Pages 241-247

  Kasaj, Adrian ^a   Röhrig, Bernd ^a   Reichert, Christoph ^a   Willershausen, Brita ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Grafts; Hydroxyapatite therapeutic use; Infrabony defects; Periodontal diseases; Periodontal regeneration

Indexed keywords

HYDROXYAPATITE; PEPGEN P 15; PEPGEN P-15;

ADULT; AGED; ANIMAL; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CATTLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALVEOLAR BONE LOSS; ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; CATTLE; DURAPATITE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 48549096559     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-008-0191-y     Document Type: Article

References (49)

1. Barros RR, Novaes AB Jr, Roriz VM, Oliveira RR, Grisi MF, Souza SL, Taba M Jr, Palioto DB (2006) Anorganic bovine matrix/P-15 "flow" in the treatment of periodontal defects: Case series with 12 months of follow-up. J Periodontol 77:1280-1287
2. Bhatnagar RS, Qian JJ, Gough CA (1997) The role in cell binding of a beta-bend within the triple helical region in collagen a1 (I) chain: structural and biological evidence for conformation tautomerism on fiber surface. J Biomol Struct Dyn 14:547-560
3. Bhatnagar RS, Qian JJ, Wedrychowska AW, Sadeghi M, Wu YM, Smith N (1999) Design of biometric habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 5:53-65
4. Caffesse RG, Kerry GJ, Chaves ES, McLean TN, Morrison EC, Lopatin DE, Caffesse ER, Stults DL (1988) Clinical evaluation of the use of citric acid and autologous fibronectin in periodontal surgery. J Periodontol 59:565-569
5. Camargo PM, Lekovic V, Weinlaender M, Nedic M, Vasilic N, Wolinsky LE, Kenney EB (2000) A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol 27:889-896
6. Cortellini P, Carnevale G, Sanz M, Tonetti MS (1998) Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 25:981-987
7. DeSanctis M, Clauser C, Zucchelli G (1996) Bacterial colonization of resorbable barrier materials and periodontal regeneration. J Periodontol 67:1193-1200
8. Eto AL, Joly JC, Jeffcoat M, de Araujo NS, de Araujo VC, Cury PR (2007) Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: A clinical and radiographic study in humans. J Periodontol 78:2277-2283
9. Froum SJ, Coran M, Thaller B, Kushner L, Scopp IW, Stahl SS (1982) Periodontal healing following open debridement flap procedures. J Periodontol 53:8-14
10. Froum SJ, Kushnek L, Scopp IW, Stahl SS (1982) Human clinical and histologic responses to durapatite in intraosseous lesions. Case reports. J Periodontol 53:719-729
11. Goldman HM, Cohen DW (1958) The infrabony pocket: Classification and treatment. J Periodontol 29:272-291
12. Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J (1986) New attachment formation in the human periodontium by guided tissue regeneration. J Clin Periodontol 13:604-616
13. Klein F, Kim TS, Hassfeld S, Staehle HJ, Reitmeier P, Holle R, Eickholz P (2001) Radiographic defect depth and width for prognosis and description of periodontal healing of infrabony defects. J Periodontol 72:1639-1646
14. Lang NK (2000) Focus on intrabony defects - conservative therapy. Periodontol 22:51-58
15. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB (2001) The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony defects in humans. J Periodontol 72:1157-1163
16. Liñares A, Cortellini P, Lang NP, Suvan J, Tonetti MS (2006) Guided tissue regenration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: Radiographic predictors and outcomes. J Clin Periodontol 33:351-352
17. Löe H (1967) The gingival index, the plaque index, and the retention index systems. J Periodontol 38:610-616
18. Lynch SE, Williams RC, Polson AM (1989) A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 16:545-548
19. Matos SM, Guerra FA, Krauser J, Marques F, Ermida JM, Sanz M (2007) Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study. J Periodontol 78:1855-1863
20. Meffert RM, Thomas JR, Hamilton KM, Brownstein CN (1985) Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 56:63-73
21. Mellonig JT, Bowers GM, Cotton WR (1981) Comparison of bone graft materials. J Periodontol 52:297-301
22. Nyman S, Lindhe J, Karring T, Rylander H (1982) New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 9:260-269
23. Nyman S, Lindhe J, Rosling B (1977) Periodontal surgery in plaque infected dentitions. J Clin Periodontol 4:240-249
24. Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, Chai JK (2001) Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 72:730-740
25. Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833-840
26. Qian JJ, Bhatnagar RS (1996) Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 31:545-554
27. Quteish D, Dolby A (1992) The use of irradiated-crosslinked human collagen membrane in guided tissue regeneration. J Clin Periodontol 19:476-484
28. Rabalais ML, Yukna RA, Mayer ET (1981) Evaluation of durapatite ceramic as an alloplast implant in periodontal osseous defects. Initial six-month results. J Periodontol 52:680-689
29. Richardson CR, Mellonig JT, Brunsvold MA, McDonnel HT, Cochran DL (1999) Clinical evaluation of Bio-Oss: A bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 26:421-428
30. Rosling B, Nyman S, Lindhe J (1976) The effect of systematic plaque control on bone regeneration in infrabony pockets. J Clin Periodontol 3:38-53
31. Sapkos SW (1986) The use of periograft in periodontal defects. Histologic findings. J Periodontol 57:7-13
32. Scarano A, Iezzi G, Petrone G, Orsini G, Degidi M, Strocchi R, Piattelli A (2003) Cortical bone regeneration with a synthetic cell-binding peptide: A histologic and histomorphometric pilot study. Implant Dent 12:318-32
33. Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M (2003) Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. J Clin Periodontol 30:73-80
34. Selvig KA, Kersten BG, Chamberlain AD, Wikesjo UM, Nilveus RE (1992) Regenerative surgery of intrabony defects using ePTFE barrier membranes. Scanning electron microscopic evaluation of retrieved membranes versus clinical healing. J Periodontol 63:974-978
35. Seyedin SM (1989) Osteoinduction: A report on the discovery and research of unique protein growth factors mediating bone development. Oral Surg Oral Med Oral Pathol 68:527-530
36. Stahl SS, Froum SJ (1987) Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation. J Periodontol 58:689-695
37. Tonetti MS, Cortellini P, Lang NP, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Rasperini G, Rossi R, Silvestri M, Topoll H, Wallkamm B, Zybutz M (2004) Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomised controlled clinical trial. J Clin Periodontol 31:770-776
38. Tonetti MS, Pini-Prato G, Cortellini P (1993) Periodontal regeneration of human infrabony defects. IV. Determinants of the healing response. J Periodontol 64:934-940
39. Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22:229-234
40. Tonetti MS, Pini-Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23:548-556
41. Trombelli L, Heitz-Mayfield L, Needleman I, Moles D, Scabbia A (2002) A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol 29:117-135
42. Tsitoura E, Tucker R, Suvan J, Laurell L, Cortellini P, Tonetti M (2004) Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative. J Clin Periodontol 31:643-647
43. Vastardis S, Yukna RA, Mayer ET, Atkinson BL (2005) Periodontal regeneration with peptide-enhanced anorganic bone matrix in particulate and putty form in dogs. J Periodontol 76:1690-1696
44. Yukna RA (1989) Osseous defect responses to hydroxylapatite grafting versus open flap debridement. J Clin Periodontol 16:389-402
45. Yukna RA (1993) Synthetic bone grafts in periodontics. Periodontol 2000 1:92-99
46. Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, Cruz R, Scott JB (1998) Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-Month results. J Periodontol 69:655-663
47. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2000) Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. Six-month results. J Periodontol 71:1671-1679
48. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2002) Thirty-six months follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) bone replacement grafts in human intrabony defects. I. Clinical findings. J Periodontol 73:123-128
49. Yukna RA, Salinas TJ, Carr RF (2002) Periodontal regeneration following use of ABM/P-15: A case report. Int J Periodontics Restorative Dent 22:146-155